KZR

Kezar Life Sciences, Inc.

Investor Moves

InvestorPortfolio ValuePortfolio ChangePosition ChangeAvg Buy PriceCurrent Price
Jim SimonsRenaissance Technologies
$-1.0M
ExitQ4 2024
$1.0M
--
--
Jim SimonsRenaissance Technologies
$-1.0M
ExitQ4 2024
$1.0M
--
--
Ken GriffinCitadel Advisors
$-200.9K
ExitQ4 2024
$201k
--
--
Ken GriffinCitadel Advisors
$-200.9K
ExitQ4 2024
$201k
--
--
Jim SimonsRenaissance Technologies
$535.8K
AddQ3 2024
$536k
--
--
Jim SimonsRenaissance Technologies
$535.8K
AddQ3 2024
$536k
--
--

News

globenewswire.com$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KZR, FORA, SLNO, and APLSglobenewswire.comApr 14prnewswire.comAre APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders?prnewswire.comApr 10globenewswire.comShareholder Alert: Ademi LLP investigates whether Kezar Life Sciences, Inc. is obtaining a Fair Price for Public Shareholdersglobenewswire.comApr 7defenseworld.netLifecore Biomedical (NASDAQ:LFCR) and Kezar Life Sciences (NASDAQ:KZR) Head-To-Head Reviewdefenseworld.netApr 2prnewswire.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Kezar Life Sciences, Inc. (NASDAQ: KZR)prnewswire.comMar 30